China National Accord Medicines Corporation Ltd.
Annual Report 2021
March 2022
Section I. Important Notice, Contents and Interpretation
Board of Directors, Supervisory Committee, all directors, supervisors and senior
executives of China National Accord Medicines Corporation Ltd. (hereinafter
referred to as the Company) hereby confirm that there are no any fictitious
statements, misleading statements, or important omissions carried in this report,
and shall take all responsibilities, individual and/or joint, for the reality,
accuracy and completion of the whole contents.
Lin Zhaoxiong, Principal of the Company, Gu Guolin, person in charger of
accounting works and Wang Ying, person in charge of accounting organ
(accounting principal) hereby confirm that the Financial Report of 2021 Annual
Report is authentic, accurate and complete.
All directors are attended the Board Meeting for report deliberation.
The profit distribution plan that deliberated and approved by the Board is:
based on total stock issued 428,126,983 shares, distributed 6.00Yuan (tax
included) bonus in cash for every 10-share hold by all shareholders, 0 shares
bonus issued (tax included) and no capitalizing of common reserves carried out.
Contents
Sction I Important Notice, Contents and Interpretation......1
Section II Company Profile and Main Financial Indexes......5
Section III Management Discussion and Analysis......10
Section IV Corporate Governance......错误！未定义书签。
Section V Enviornmental and Social Responsibility......错误！未定义书签。
Section VI Important Events ......83
Section VII Changes in shares and particular about shareholders......错误！未定义书签。9
Section VIII Preferred Stock......错误！未定义书签。9
Section IX Bonds......错误！未定义书签。0
Section X Financial Report......错误！未定义书签。1
DocumentsAvailable for Reference
I.The financial statements carried with the signature and seals of the person in charge of the
Company, person in charger of accounting works and person in charge of accounting
organ(accounting supervisor);
II.The original audit report bearing the seal of accounting firm and the original audit report
signed and seal by the CPA;
III.Original text of all documents of the Company as well as the manuscript of the
announcement disclosed on the website designated by CSRC.
Interpretation
Items Refers to Contents
Listed Company, Company, the Company, Refers to China National Accord Medicines Corporation Ltd.
Sinopharm Accord, the Group
SINOPHARM Refers to China National Pharmaceutical Group Corporation
Sinopharm Holding Refers to Sinopharm Group Co., Ltd, Controlling shareholder of the Company
Company Law Refers to Company Law of the People’s Republic of China
Securities Law Refers to Securities Law of the People’s Republic of China
Yuan, 10 thousand Yuan, 100 million Yuan Refers to RMB, RMB 10 thousand, RMB 100 million
Terminology: Refers to
SPD hospital logistics supply chain extension business, IVD
4D business Refers to diagnostic reagent business, CSSD disinfection service, and MWD
equipment life cycle management business
GPO Refers to Group purchasing organizations
Abbreviation: Refers to
Sinopharm Holding Guangzhou Refers to Sinopharm Holding Guangzhou Co., Ltd.
Guoda Drugstore Refers to Sinopharm Holding Guoda Drugstore Co., Ltd.
Sinopharm Holding Guangxi Refers to Sinopharm Holding Guangxi Co., Ltd.
China National Zhijun Refers to China National Zhijun (Shenzhen) Pharmaceutical Co., Ltd.
Zhijun Pharmacy Trade Refers to Shenzhen Zhijun Pharmacy Trade Co., Ltd.
Zhijun Pingshan Refers to China National Zhijun (Shenzhen) Pingshan Pharmaceutical Co., Ltd.
Main Luck Pharmaceuticals Refers to Shenzhen Main Luck Pharmaceuticals Inc.
Section II Company Profile and Main Financial Indexes
I. Company information
Short form of the stock Sinopharm Accord, Accord B Stock code 000028, 200028
Stock exchange for listing Shenzhen Stock Exchange
Name of the Company (in 国药集团一致药业股份有限公司
Chinese)
Short form of the Company 国药一致
(in Chinese)
Foreign name of the Company China NationalAccord Medicines Corporation Ltd.
(if applicable)
Short form of foreign name of SinopharmAccord
the Company (if applicable)
Legal representative Lin Zhaoxiong
Registrations add. Accord Pharm. Bldg , No. 15, Ba Gua Si Road, Futian District, Shenzhen, Guangdong Province
Code for registrations add
查看PDF原文
